Xortx Therapeutics earnings were -$1.4M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest XRTX earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$523.9k, up 8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, XRTX reported annual earnings of -$2.3M, with 41.8% growth. The next XRTX earnings date is Nov 13, 2025.
What were Xortx Therapeutics's earnings last quarter?
Xortx Therapeutics (NASDAQ: XRTX) reported Q2 2025 earnings per share (EPS) of -$0.14, up 415.91% year over year. Total XRTX earnings for the quarter were -$523.87 thousand. In the same quarter last year, Xortx Therapeutics's earnings per share (EPS) was $0.04.
The next XRTX earnings date is Invalid Date. Add XRTX to your watchlist to be reminded of Xortx Therapeutics's next earnings date.
What was XRTX's earnings growth in the past year?
As of Xortx Therapeutics's earnings date in Q3 2025, Xortx Therapeutics's earnings has grown year over year. XRTX earnings in the past year totalled -$1.37 million.
Is Xortx Therapeutics profitable or losing money?
As of the last Xortx Therapeutics earnings report, Xortx Therapeutics is currently losing money. Xortx Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$1.37 million, a 26.83% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.